The UK drugs regulator has removed postoperative pain from prolonged-release opioid licences due to increased risks of ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) isn't sufficiently funded to meet its obligations, according to a new report commissioned by a pharma trade organisation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback